Avant Diagnostics, Inc

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$115K

6 transactions

Summary

Avant Diagnostics, Inc is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $0Sales: $40K6 insiders

Date	Insider	Type	Value
2018-08-20	Busch Jeffrey	A	$50K
2018-08-23	RUXIN MICHAEL I(Chief Executive Officer)	A	$25K
2017-08-23	Joint reporting: INFUSION 51A, L.P.; Stephens Jeffrey; VanderMeer Scott	Sell	$20K
2017-08-09	Joint reporting: INFUSION 51A, L.P.; Stephens Jeffrey; VanderMeer Scott	Sell	$20K
2010-05-24	VOLLMERS ALVARO(See Remarks)	J	$0
2010-05-04	VOLLMERS ALVARO(See Remarks)	Buy	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Avant Diagnostics, Inc — Contributions, Lobbying & Contracts | Poliscope